Sinovac gets world's 1st production license for A/H1N1 flu vaccine

Source: Xinhua | September 3, 2009, Thursday |

Online Edition

CHINA approved today the A/H1N1flu vaccine produced by domestic pharmaceutical company Sinovac, making it the first to get a production license in the global race.

The State Food and Drug Administration (SFDA) issued the license for Sinovac' s vaccine called Panflu.1 today, after it passed SFDA' s experts evaluation on Aug. 31.

Panflu.1 could safely be given to people aged from 3 to 60 years old in a single shot, 15 microgram dose, according to the evaluation report.

Sinovac had the capacity to produce 5 million doses of vaccine before Oct.1, and 20 million to 30 million doses per year, said president Yin Weidong.

Another A/H1N1 flu vaccine, produced by Chinese pharmaceutical company Hualan Biological Engineering Inc., is also hopeful to be given the country's second approval this week.

Nation

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Sinovac gets world's 1st production license for A/H1N1 flu vaccine

Email this to your friend